FDA

Health Lev Facher

Drug treatment that insists on abstinence? Federal agencies are just saying no

The Readout Elaine Chen

STAT Plus: Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week

In the Lab Nicholas Florko and Sarah Owermohle

What the rescheduling of marijuana might — and might not — mean for scientific research

Politics Lizzy Lawrence

STAT Plus: Clinical lab trade group sues FDA over plan to regulate lab-developed tests

The Readout Elaine Chen

STAT Plus: Wegovy linked to lower risk of alcohol use disorder in real-world study

The Readout Meghana Keshavan

STAT Plus: Biotech’s most interesting fundraisings from the last week

The Readout Meghana Keshavan

STAT Plus: More tumult at BIO amid the company’s fourth CEO in four years

Pharma Olivia Goldhill

STAT Plus: After MDMA therapy, she considered suicide. The trial data tell a different story

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Pharma’s losing bet in New Jersey

The Readout Elaine Chen

STAT Plus: Maryland takes first steps to cap drug costs

The Readout Elaine Chen

STAT Plus: Blackstone wants in on red-hot immunology market

The Readout Elaine Chen

STAT Plus: Leqembi gets closer to being offered as an injection

Health Nicholas Florko

My rendezvous with the raw milk black market: quick, easy, and unchecked by the FDA

The Readout Elaine Chen

Is Novavax a new meme stock?

Politics Rachel Cohrs Zhang, Lizzy Lawrence, and Nicholas Florko

STAT Plus: USDA, FDA turf battles hamper responses to outbreaks like H5N1 bird flu

Health tech Brittany Trang

STAT Plus: Cue Health’s Covid-19 tests could give false results, FDA warns

The Readout Meghana Keshavan

STAT Plus: We now know Tome’s gene editing target

Pharmalot Ed Silverman

STAT Plus: FDA is criticized for taking a ‘ministerial’ role in sorting out some pharma patents

The Readout Meghana Keshavan

STAT Plus: The public wants Medicare to cover obesity drugs

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: CDC goes hard on military pets

The Readout Elaine Chen

STAT Plus: Yet another big financing round in immunology

First Opinion Sara Gorman, Scott C. Ratzan, and Kenneth H. Rabin

H5N1 communication has been strictly for the birds. Didn’t the federal government learn anything from Covid?

Health tech Lizzy Lawrence

STAT Plus: Software glitch caused Tandem insulin pumps to prematurely shut down, FDA warns

The Readout Elaine Chen

STAT Plus: Pharma has over $500B in capital for deals

The Readout Elaine Chen

STAT Plus: Vertex starts gene therapy Casgevy in five patients 

The Readout Meghana Keshavan

STAT Plus: ICER casts doubt on Sarepta’s DMD gene therapy

Health Megan Molteni

Pasteurization inactivates H5N1 bird flu in milk, new FDA and academic studies confirm

The Readout Elaine Chen

STAT Plus: The latest government crackdowns on biotech you need to know

The Readout Elaine Chen

STAT Plus: FDA wants to hear your thoughts on advisory committees